Actively Recruiting

Phase 4
Age: 18Years +
All Genders
NCT04869436

Olfactory Outcomes of Dupilumab Treatment for Nasal Polyposis

Led by London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's · Updated on 2024-12-20

27

Participants Needed

1

Research Sites

228 weeks

Total Duration

On this page

Sponsors

L

London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's

Lead Sponsor

M

Mount Sinai Hospital, Canada

Collaborating Sponsor

AI-Summary

What this Trial Is About

The study aims to investigate the olfactory TDI score (Threshold, Discrimination, Identification) using the Sniffin' sticks test for patients with chronic rhinosinusitis with nasal polyps (CRSwNP) on dupilumab. Twenty-seven adult patients will be followed up during the treatment with dupilumab on three visits to the Otolaryngology Clinic (Baseline, 3 months and 6 months). The primary endpoint will be the TDI score. Nasal polyp score, Quality of Olfactory Disorders - negative symptoms (QOD-NS symptom scores), SNOT-22 will be secondary endpoints.

CONDITIONS

Official Title

Olfactory Outcomes of Dupilumab Treatment for Nasal Polyposis

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Patients older than 18 years old
  • Diagnosis of chronic rhinosinusitis with nasal polyps
  • Presence of olfactory loss
  • Clinical indication for treatment with Dupilumab
Not Eligible

You will not qualify if you...

  • Olfactory loss caused by sinonasal malignancies
  • Olfactory loss caused by trauma
  • Idiopathic olfactory loss
  • Use of cocaine
  • Olfactory loss related to COVID-19
  • Pregnancy

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

St. Joseph's Health Care

London, Ontario, Canada, N5A 4V2

Actively Recruiting

Loading map...

Research Team

C

Cristian Dihel, MD

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

NA

Model

SINGLE_GROUP

Primary Purpose

TREATMENT

Number of Arms

1

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

Olfactory Outcomes of Dupilumab Treatment for Nasal Polyposis | DecenTrialz